Literature DB >> 10023660

The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin.

E Latres1, D S Chiaur, M Pagano.   

Abstract

Ubiquitin-conjugation targets numerous cellular regulators for proteasome-mediated degradation. Thus, the identification of ubiquitin ligases and their physiological substrates is crucially important, especially for those cases in which aberrant levels of regulatory proteins (e.g., beta-catenin, p27) result from a deregulated ubiquitination pathway. In yeast, the proteolysis of several G1 regulators is controlled by ubiquitin ligases (or SCFs) formed by three subunits: Skp1, Cul A (Cdc53), and one of many F-box proteins. Specific F-box proteins (Fbps) recruit different substrates to the SCF. Although many Fbps have been identified in mammals, their specific substrates and the existence of multiple SCFs have not yet been reported. We have found that one human Fbp, beta-Trcp (beta-Transducin repeat containing protein), does indeed form a novel SCF with human Skp1 and Cul1. Consistent with recent reports indicating that Xenopus and Drosophila beta-Trcp homologs act as negative regulators of the Wnt/beta-catenin signaling pathway, we report here that human beta-Trcp interacts with beta-catenin in vivo. Furthermore, beta-catenin is specifically stabilized in vivo by the expression of a dominant negative beta-Trcp. These results indicate that the Cul1/Skp1/beta-Trcp complex forms a ubiquitin ligase that mediates the degradation of beta-catenin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10023660     DOI: 10.1038/sj.onc.1202653

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  169 in total

Review 1.  Roles of Wnt proteins in neural development and maintenance.

Authors:  A Patapoutian; L F Reichardt
Journal:  Curr Opin Neurobiol       Date:  2000-06       Impact factor: 6.627

2.  ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligase.

Authors:  I Lassot; E Ségéral; C Berlioz-Torrent; H Durand; L Groussin; T Hai; R Benarous; F Margottin-Goguet
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1.

Authors:  W Tao; D Pennica; L Xu; R F Kalejta; A J Levine
Journal:  Genes Dev       Date:  2001-07-15       Impact factor: 11.361

Review 4.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

5.  SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation.

Authors:  G Wu; S Lyapina; I Das; J Li; M Gurney; A Pauley; I Chui; R J Deshaies; J Kitajewski
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

6.  Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation.

Authors:  A Montagnoli; F Fiore; E Eytan; A C Carrano; G F Draetta; A Hershko; M Pagano
Journal:  Genes Dev       Date:  1999-05-01       Impact factor: 11.361

7.  Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease.

Authors:  Juliette D Godin; Ghislaine Poizat; Miriam A Hickey; Florence Maschat; Sandrine Humbert
Journal:  EMBO J       Date:  2010-06-08       Impact factor: 11.598

8.  Exploring the functional complexity of cellular proteins by protein knockout.

Authors:  Jianxuan Zhang; Ning Zheng; Pengbo Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-30       Impact factor: 11.205

9.  Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts.

Authors:  Rongrong Zhang; Babatunde O Oyajobi; Stephen E Harris; Di Chen; Christopher Tsao; Hong-Wen Deng; Ming Zhao
Journal:  Bone       Date:  2012-09-29       Impact factor: 4.398

10.  SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.

Authors:  Jianping Jin; Takahiro Shirogane; Lai Xu; Grzegorz Nalepa; Jun Qin; Stephen J Elledge; J Wade Harper
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.